Background Image
Menu

Latest News

Three weeks: Four trophies: One BWB!

26 May 2016

Three weeks: Four trophies: One BWB!

BWB’s commitment to the next generation of engineering talent has secured national recognition from one of the industry’s most influential organisations – and a remarkable awards double! ACE – the Association for Consultancy and Engineering – held...

Yospace wins at Mediatel’s Connected Consumer Awards

12 May 2016

Yospace wins at Mediatel’s Connected Consumer Awards

Yospace is delighted to have won in the Connected Content Service of the Year category of Mediatel’s prestigious Connected Consumer Awards. The category recognizes innovations such as new advertising models and formats and was awarded to Yospace for its work with Channel 4...

Blueberry Therapeutics raises £3m led by GM&C Life Sciences Fund

5 May 2016

Blueberry Therapeutics raises £3m led by GM&C Life Sciences Fund

Alderley Park, Cheshire, UK - 5th May 2016. Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund...

Yospace Wins NewBay Media’s Best of Show Award, Presented by TV Technology

28 April 2016

Yospace Wins NewBay Media’s Best of Show Award, Presented by TV Technology

Yospace is delighted to have won NewBay Media’s Best of Show Award, presented at the 2016 NAB Show in Las Vegas by TV Technology. The award recognises the importance of Yospace’s Dynamic Ad Insertion platform in enabling live channels to be monetised when viewed...

Catapult exits Food and Drug Analytical Services

13 April 2016

Catapult exits Food and Drug Analytical Services

Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates

6 April 2016

Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates

Oxford BioTherapeutics (OBT), a company developing a range of innovative Antibody Drug Conjugates (ADCs) for the treatment of cancer and Nerviano Medical Sciences (Nerviano), a company of the NMS Group dedicated to the discovery and development of breakthrough treatments for...

Sky Media to use Yospace’s live ad insertion solution for Sky Go

17 March 2016

Sky Media to use Yospace’s live ad insertion solution for Sky Go

Sky Media has chosen Yospace to provide a dynamic advertisement replacement solution for Sky Go, the leading ‘TV everywhere’ service in Europe. In addition to enabling dynamic ad serving on Sky Go Linear for the first time, Sky is now also able to reproduce the key...

Abzena issues business update – strong second half momentum

15 March 2016

Abzena issues business update – strong second half momentum

Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, provides the following update. Broadening of service offering … As part of...

GM&C Life Sciences Fund announces first investments

7 March 2016

GM&C Life Sciences Fund announces first investments

The GM&C Life Sciences Fund has announced that it has concluded its first two investments in February. The Fund, which is managed by Catapult Ventures and targets exciting life science investments in the Greater Manchester and Cheshire regions, has invested in...

Michelson Diagnostics’ Dynamic OCT Imaging Technology reveals changes in Skin Blood Vessels in Real-Time

1 March 2016

Michelson Diagnostics’ Dynamic OCT Imaging Technology reveals changes in Skin Blood Vessels in Real-Time

Maidstone, UK, 26 February 2016 – Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces data showing that its Dynamic OCT imaging technology is able to visualise in...